2022
DOI: 10.1016/j.ejso.2021.12.426
|View full text |Cite
|
Sign up to set email alerts
|

Imaging of Lumpectomy Surface with Large Field-of-View Confocal Laser Scanning Microscopy ‘Histolog® Scanner’ for Breast Margin Assessment in comparison with Conventional Specimen Radiography

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(4 citation statements)
references
References 22 publications
0
4
0
Order By: Relevance
“…Fourteen studies were included in this systematic review, evaluating breast cancer, [18][19][20][21][22][23][24][25][26][27][28][29][30][31] prostate cancer, 20,27 brain tumors, [26][27][28] kidney, 29 bladder, 30 and conjunctival tumors. 31 Of these, six studies used the VivaScope FCM (München, Germany), four used the Histolog FCM (Lausanne, Switzerland), three used the Carl Zeiss FCM (Jena, Germany), and one used a multimodal microscope that combined fluorescence microscopy, OCT, and FCM.…”
Section: Results Of the Included Studiesmentioning
confidence: 99%
See 3 more Smart Citations
“…Fourteen studies were included in this systematic review, evaluating breast cancer, [18][19][20][21][22][23][24][25][26][27][28][29][30][31] prostate cancer, 20,27 brain tumors, [26][27][28] kidney, 29 bladder, 30 and conjunctival tumors. 31 Of these, six studies used the VivaScope FCM (München, Germany), four used the Histolog FCM (Lausanne, Switzerland), three used the Carl Zeiss FCM (Jena, Germany), and one used a multimodal microscope that combined fluorescence microscopy, OCT, and FCM.…”
Section: Results Of the Included Studiesmentioning
confidence: 99%
“…Three of the included studies showed improved accuracy for diagnosing the presence of a PSM compared with FFPE. 18,19 The multimodal bespoke microscope used in the study by Scimone et al 21 had the highest reported accuracy, although the interpretation of the results should be taken with care owing to the study being sponsored by the industry and high risk of bias in patient selection. Unfortunately, no other studies evaluating this platform were found.…”
Section: Breast Cancermentioning
confidence: 99%
See 2 more Smart Citations